GNI GROUP LTD.
Contact Us
About Us
About Us TOP
Message
Business Model
Main Products
Management Policy
Company Overview
Board of Directors
Main Group Structure
Office
Corporate governance
R&D
R&D TOP
Pipeline
Discovery Research
Research publications
Investor Relations
Investor Relations TOP
IR News
Information
IR Materials
IR Calendar
IR Email Subscription
Electronic Public Notices
Sustainability/ESG
Sustainability/ESG TOP
Sustainability Initiatives
ESG Data
Contact Us
Site Map
Privacy Policy
Terms of Use
ソーシャルメディアポリシー
2010's Information
トップページ
Information
2010年
All
2025
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2010/11/29
Notice of investments in China
2010/11/16
Notice of Increasing the Capital of Shanghai Genomics
2010/10/20
GNI Receives F351 Patent Allowance in Japan
2010/10/17
The 12th National Clinical Pharmacology Conference
2010/09/17
Shanghai Genomics Issued US Patent Covering F351
2010/09/17
Pharmaceutical & Biotechnology Pioneer Forum 2010
2010/08/26
GNI Receives F351 Patent Allowance in Canada
2010/07/30
Notice of reaching agreement for co-development of F351 in China
2010/07/26
Shanghai Genomics Reports Human Phase I Trial Data of F351
2010/07/20
BioBusiness Asia Conference 2010
1
2
3
4
>